Predicting autism at birth

Medical Hypotheses

Volumn 81, Issue 1, 2013, Pages 21-25

  Steinman, Gary ^a  

^a Touro University College of Pharmacy and School of Osteopathic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN; SEROTONIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; AUTISM; BIRTH; DELIVERY; HUMAN; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; PREDICTION; QUANTITATIVE ANALYSIS;

AUTISTIC DISORDER; HUMANS; INFANT, NEWBORN; MYELIN BASIC PROTEIN; SEROTONIN; SOMATOMEDINS;

EID: 84878526536     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.03.034     Document Type: Article

References (60)

1. US Food and Drug Administration. http://www.fda.gov/biologicsbloodvaccines/Safetyavailability/vaccinesafety/ucm096228.htm#THI.
2. Kern J.K., Jones A.M. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxic Environ Health B Crit Rev 2006, 9(6):485-499.
3. Cannel J.J. Autism and vitamin D. Med Hypoth 2008, 70(4):750-759.
4. Zafeiriou D.I., Ververi A., Vagiami E. Childhood autism and associated comorbidities. Brain Dev 2007, 29(5):257-272.
5. Steinman G., Mankuta D. Insulin-like growth factor and the etiology of autism. Med Hypotheses 2013, 80(4):475-480.
6. Ye P., Li L., Richards R.G., DiAugustine R.P., D'Ercole A.J. Myelination is altered in insulin-like growth factor-1 null mutant mice. J Neurosci 2002, 22(14):6041-6051.
7. Van Kleffens M., et al. The IGF system during fetal-placental development of the mouse. Mol Cell Endocrinol 1998, 140:129-135.
8. Dupont J., Holzenberger M. Biology of insulin-like growth factors in development. Birth Def Res (Part C) 2003, 69:257-271.
9. D'Ercole A.J., et al. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 1996, 13:227-255.
10. Arends N., Johnston L., Hokken-Koelega A., et al. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). J Clin Endocrinol Metab 2002, 87(6):2720-2724.
11. Blanco C.L., Ferry R.J. Jr. The insulin-like growth factor axis in the fetus and neonate in IGF and Nutrition in Health and Disease 2005, 33-143. Humana Press, Totowa, NJ. M.S. Houston, N.M.P. Holly, E.L. Feldman (Eds.).
12. Durkin M.S., Maenner M.J., Newschaffer C.J., et al. Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol 2008, 168(11):1268-1276.
13. Patterson P.H. Maternal infection and immune involvement in autism. Trends Mol Med 2011, 17(7):389-394.
14. Geschwind D.H. Genetics of autism spectrum disorder. Trends Cogn Sci 2011, 15(9):409-416.
15. Hsiao E.Y., Patterson P.H. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain, Behavior, and Immunity 2010, 25(4):604-615.
16. Benirschke K., Kaufmann P. Pathology of the human placenta 2000, Springer-Verlag, New York, pp. 591-608. 4th ed.
17. Meyer U., Yee B.K., Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist 2007, 13:241-256.
18. Brown AS, et al. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psych. doi:10.1038/mp.2012.197.
19. Libbey J.E., et al. Autistic disorder and viral infections. J Neurovirol 2005, 11:1-10.
20. Fatemi S.H., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002, 22(1):25-33.
21. Zikopoulos B., Barbas H. Changes in prefrontal axons may disrupt the network in autism. J Neurosci 2010, 30(44):14595-14608.
22. Bondy C.A., Lee W.H., Cheng C.M. Insulin-like growth factor I (IGFI) and brain development in Insulin-like growth factors 2003, 37-157. Kluwer Academic/Plenum Publishers, New York. D. LeRoith, W. Zumkeller, R.C. Baxter (Eds.).
23. Koul O. Myelin and autism. The neurobiology of autism 2005, 150-163. Johns Hopkins Univ. Press. 2nd edition. M. Bauman, T.L. Kemper (Eds.).
24. Ye P., Li L., Richards R.G., DiAugustine R.P., D'Ercole A.J. Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci 2002, 22(14):6041-6051.
25. Granero-Molto F. Autocrine effects of mesenchymal stem cells expressing IGF-1 rescue the fracture-healing defects of Irs1 knockout mice. Endocr Rev 2011, 32:OR12-OR15.
26. Laron Z. Laron syndrome: primary GH insensitivity or resistance. Insulin-like growth factors 2003, 467-487. Kluwer Academic/Plenum Publishers, New York. D. LeRoith, W. Zumkeller, R. Baxter (Eds.).
27. Shevah O., Lornreigh L., Galatzer A., Laron Z. The inteelectual capacity of patients with Laron syndrome differs with various molecular defects of the growth hormone receptor gene. Correlation with CNS abnormalities. Horm Metab Res 2005, 37(12):757-760.
28. Kranzler J.H., et al. Normal intelligence with severe insulin-like growth factor 1 deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogenous population. J Clin Endocrinol Metab 1998, 83:1953-1958.
29. Woods K.A., Camacho-Hübner C., Savage M.O., Clark A.J. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. NEJM 1996, 335:1363-1367.
30. Gluckman P.D., Pinal C.S. Regulation of fetal growth by the somatotrophic axis. J Nutr 2003, 133:S1741-S1746.
31. Savage M.O., et al. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron Syndrome). J Clin Endocrinol Metab 1991, 77(6):1465-1471.
32. Laron Z., Iluz M., Kauli R. Head circumference in untreated and IGF-I treated patients with Laron Syndrom: comparison with untreated and hGH-treated children with isolated growth hormone deficiency. Growth Horm IGF Res 2012, 22(2):49-52.
33. Vanhala R., Turpeinen U., Riikonen R. Low levels of insulin-like growth factor-1 in cerebrospinal fluid in children with autism. Dev Med Child Neurol 2001, 43:614-616.
34. Fombonne E., Roge B., Claverie J., Courty S., Fremolle J. Microcephaly and macrocephaly in autism. J Autism Dev Disord 1999, 29:113-119.
35. Morell P., Quarles R.H. Myelin formation, structure, and biochemistry in basic neurochemistry. Proceedings of Studies 1999, 81-92. Lippincott Williams & Wilkins, Philadelphia. G. Siegel (Ed.).
36. Wei H., Zou H., Sheikh A.M., et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion migration and synaptic formation. J Neuroinflam 2011, doi:10.1186/1742-2094.8.52.
37. Dammann O., Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997, 42:1-8.
38. Singh V.K., et al. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 1993, 7(1):97-103.
39. Paterson P.Y., et al. Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis. J Neurol Sci 1981, 52(1):37-51.
40. Lalive P.H., et al. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating disease from viral encephalitis in children. Mult Scler 2011, 17(3):297-302.
41. Mattson M.P., Maudsley S., Martin B. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1. BDNF and serotonin. Ageing Res Rev 2004, 3:445-464.
42. Yao D., et al. Insulin-like growth factor I treatment reduced demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. PNAS 1995, 92:6190-6194.
43. Mostafa G.A., Al-Ayadhi L.Y. A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children. J Neuroinflammation 2011, doi:10.1186/1742-2094-8-71.
44. Leboyer M., et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry 1999, 45:158-163.
45. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res Bull 2001, 56:479-485.
46. Mansour M., et al. Brain derived neurotrophic factor in autism. Curr Psychiatry 2010, 17(1):23-29.
47. Yirmiya N., et al. Evidence for an association with the serotonin transporter promoter region polymorphism and autism. A J Med Genet 2001, 105(4):381-386.
48. Schain R.J., Freeman B.J. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 1961, 58:315-320.
49. Veenstra-Vanderweele J, et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. http://www.pnas.org/cgi/doi/10.1073/pnas.1112345109.
50. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse genetics. Nature Rev Neurosci 2003, 4:1002-1012.
51. Hoshaw B.A., et al. Antidepressant like behavioral effects of IGF-I produced by enhanced serotonin transmission. Eur J Pharmacol 2008, 594:109-116.
52. Deoni S.C.L., Mercure E., Blasi A., et al. Mapping infant brain myelination with magnetic resonance imaging. J Neurosci 2011, 31(2):784-791.
53. Pinto-Martin J.A., Levy S.E., Feldman J.F., et al. Prevalence of autism spectrum disorder in adolescents born weighing <2000 grams. Pediatrics 2011, 128(4):2010-2846.
54. Ohkawa N., Shoji H., Kitamura T., et al. IGF-1, leptin and active ghrelin levels in very low birth weight infants during the first 8 weeks of life. Acta Paediatr 2010, 99:37-41.
55. Chernausek S.D., et al. Long-term treatment with recombinant insulin-like growth factor (IGF-I) in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 2007, 92:902-910.
56. Pilon M, Kolata G. New to most fans, IGF-1 has long been banned as a performance enhancer. NY, Times, 1/29/2013, p. B13.
57. Eremia S.C., et al. Fetal and amniotic insulin-like growth factor-I supplements improve growth rate in intrauterine growth restriction fetal sheep. Endocrinology 2007, 148(6):2963-2972.
58. van Heebst D. Insulin, IGF-1 and longevity. Aging Dis 2010, 1(2):147-157.
59. Ma J., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF-I) and IGF-binding protein-3. J Natl Cancer Inst 1999, 91(7):620-625.
60. Wang S., et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse of congenital hypomyelination. Cell Stem Cell 2013, 12(2):252-264.